Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles

Informazioni relative al progetto

SMARTRIOX

ID dell’accordo di sovvenzione: 811744

DOI 10.3030/811744

Progetto chiuso

Data della firma CE 25 Maggio 2018

Data di avvio 1 Giugno 2018

Data di completamento 31 Ottobre 2021

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale € 2 847 667,50

Contributo UE € 1 993 367,25

Coordinato da

TRIOX NANO LTD
Israel

Risultati finali

Websites, patent fillings, videos etc. (1)

Project Web page

It will contain information about the project’s Coordinator and Objectives and Stakeholders. The website will be updated with new information on Meetings, Deliverables and main Milestones. Website visitors will be able to subscribe to the TXN770 Newsletter.